@article{ART003055358},
author={Afifa Naaz},
title={Effect of unani formulation in PCOS: A case report},
journal={CELLMED},
issn={3022-6805},
year={2024},
volume={14},
number={2},
pages={5-5},
doi={10.5667/CellMed.2024.005}
TY - JOUR
AU - Afifa Naaz
TI - Effect of unani formulation in PCOS: A case report
JO - CELLMED
PY - 2024
VL - 14
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 5
EP - 5
SN - 3022-6805
AB - PCOS is the most common endocrine pathology in females of reproductive worldwide. The prevalenceranges between 5% and 15% depending on the diagnostic criteria applied.Its etiology involves both geneticand environmental factors. Typically, women with PCOS show clinical and biochemical hyperandrogenism,oligoanovulation, and micropolycystic morphology of the ovaries. Unani formulation containingNankhwah , Badiyan and Wajturki possessing the properties of Mudirr-i-Bawl-o- Hayd, mujaff –i-Balgham ,Munaffis-i- balgham , Muhallil, Muqawwi-i-Jigar were used in the form of Joshanda 6gm BDStarting from 5 days prior to expected period date to 5 days during menses for 3 cycles, which led to regainregularity of menses, correcting the amount of flow and reducing the ovarian volume on US. Thus unanimedications have the potential to treat ths symtoms of PCOS and improve the quality of life of women.
KW - Polycystic ovarian syndrome;Ihtibas al-Tamth;unani formulation;Nankhawah;Badiyan;Waj turki;Mudirr-i-Bawl-o- Hayd;Joshanda
DO - 10.5667/CellMed.2024.005
ER -
Afifa Naaz. (2024). Effect of unani formulation in PCOS: A case report. CELLMED, 14(2), 5-5.
Afifa Naaz. 2024, "Effect of unani formulation in PCOS: A case report", CELLMED, vol.14, no.2 pp.5-5. Available from: doi:10.5667/CellMed.2024.005
Afifa Naaz "Effect of unani formulation in PCOS: A case report" CELLMED 14.2 pp.5-5 (2024) : 5.
Afifa Naaz. Effect of unani formulation in PCOS: A case report. 2024; 14(2), 5-5. Available from: doi:10.5667/CellMed.2024.005
Afifa Naaz. "Effect of unani formulation in PCOS: A case report" CELLMED 14, no.2 (2024) : 5-5.doi: 10.5667/CellMed.2024.005
Afifa Naaz. Effect of unani formulation in PCOS: A case report. CELLMED, 14(2), 5-5. doi: 10.5667/CellMed.2024.005
Afifa Naaz. Effect of unani formulation in PCOS: A case report. CELLMED. 2024; 14(2) 5-5. doi: 10.5667/CellMed.2024.005
Afifa Naaz. Effect of unani formulation in PCOS: A case report. 2024; 14(2), 5-5. Available from: doi:10.5667/CellMed.2024.005
Afifa Naaz. "Effect of unani formulation in PCOS: A case report" CELLMED 14, no.2 (2024) : 5-5.doi: 10.5667/CellMed.2024.005
